Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment Strategies in Type 2 Diabetes Mellitus with Premixed Insulin Analogues and Metformin
2006-003076-35Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of insulin lispro + insulin lispro protamine, insulin lispro mix25, biphasic insulin aspart and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Started Jul 2006; status: completed.
02
Drugs
insulin lispro + insulin lispro protamineinsulin lispro mix25biphasic insulin aspartmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-003076-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003076-35.